NCT06818643: A Study to Evaluate the Safety and Efficacy of MK-3120 in Participants With Advanced Solid Tumors (MK-3120-002)
- State
- Under way
- Phase
- Phase 1 and Phase 2
- People
- 270 planned
- Started
- 25 Mar 2025
- Primary completion
- 8 Feb 2028
- Arms
- Arm 1 Dose level 1, Arm 2 Dose level 2
- Results
- None posted
- 10 Feb 2025: Trial registered
- 25 Mar 2025: Trial started